MedTrace Logo

ChOcolate COnsumption And Blood Pressure (COCOA-BP): A Wearable Devices Pilot Trial

NCT02764203 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2017-10-04

No results posted yet for this study

Summary

The COCOA-BP Trial is designed to assess the impact of 50g daily dark chocolate intake on blood pressure and compare outcome data derived from wearable/digital health devices to data derived from standard methods. Additionally, the usability of the wearable technology will be evaluated.

Conditions

  • Health Behavior
  • Blood Pressure

Interventions

OTHER

Dark Chocolate

50g dark chocolate consumed for a period of 2 weeks

DEVICE

Wearable devices

Up to three wearable devices will be worn by the subject to measure parameters such as heart rate, blood pressure and number of steps

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Thomas Christen, MD, PhD · Sponsor GmbH

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-16
Primary Completion
2017-09-12
Completion
2017-09-12

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02764203 on ClinicalTrials.gov